A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas
暂无分享,去创建一个
S. Reddy | I. Alchanati | D. Kalvakolanu | J. Hu | I Alroy | I Alchanati | S C Nallar | P Sun | L Gao | J Hu | A Stein | E Yakirevich | D Konforty | X Zhao | S P Reddy | M B Resnick | D V Kalvakolanu | E. Yakirevich | I. Alroy | L. Gao | P. Sun | M. Resnick | X. Zhao | A. Stein | S. C. Nallar | D. Konforty | Shreeram C Nallar | J. Hu | Avi Stein | Iris Alchanati | Peng Sun | Junbo Hu | Evgeny Yakirevich | Iris Alroy | Sekhar P. Reddy | Murray B. Resnick
[1] A. Kibel,et al. Tumour suppression by the human von Hippel-Lindau gene product , 1995, Nature Medicine.
[2] A. Kimchi,et al. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. , 1991, Science.
[3] P. Choyke,et al. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. , 1999, The American journal of pathology.
[4] P. Shapiro,et al. Identification of GRIM-19, a Novel Cell Death-regulatory Gene Induced by the Interferon-β and Retinoic Acid Combination, Using a Genetic Approach* , 2000, The Journal of Biological Chemistry.
[5] H. Cai,et al. Interferon-α activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes , 2002 .
[6] F. Belardelli,et al. Endogenous type I interferons as a defense against tumors. , 2002, Cytokine & growth factor reviews.
[7] Richard J. Simpson,et al. Proteins and proteomics : a laboratory manual , 2003 .
[8] L. Baggetto,et al. Deviant energetic metabolism of glycolytic cancer cells. , 1992, Biochimie.
[9] W. Kaelin,et al. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] Q. Zeng,et al. GRIM-19, a Cell Death Regulatory Protein, Is Essential for Assembly and Function of Mitochondrial Complex I , 2004, Molecular and Cellular Biology.
[11] J. Gnarra,et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.
[12] F. McGovern,et al. Renal-cell carcinoma. , 2005, The New England journal of medicine.
[13] M. Runswick,et al. GRIM-19, a Cell Death Regulatory Gene Product, Is a Subunit of Bovine Mitochondrial NADH:Ubiquinone Oxidoreductase (Complex I)* , 2001, The Journal of Biological Chemistry.
[14] R A Jungmann,et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Housman,et al. p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.
[16] W. Alexander,et al. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. , 2004, Annual review of immunology.
[17] J R Griffiths,et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.
[18] J. Choe,et al. Viral Interferon Regulatory Factor 1 of Kaposi's Sarcoma-Associated Herpesvirus Interacts with a Cell Death Regulator, GRIM19, and Inhibits Interferon/Retinoic Acid-Induced Cell Death , 2002, Journal of Virology.
[19] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[20] Chuan-Yuan Li,et al. GW112, A Novel Antiapoptotic Protein That Promotes Tumor Growth , 2004, Cancer Research.
[21] Ashok R Venkitaraman,et al. Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.
[22] G. Semenza,et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways , 2005, Oncogene.
[23] Joe W. Gray,et al. The Molecular Basis of Cancer , 1985 .
[24] D. Kalvakolanu. The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression. , 2004, Cytokine & growth factor reviews.
[25] J. Barrett,et al. Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1‐13.2 , 1999, The Prostate.
[26] Guochang Huang,et al. GRIM‐19, a death‐regulatory gene product, suppresses Stat3 activity via functional interaction , 2003, The EMBO journal.
[27] R. Chandraratna,et al. Therapeutic applications for ligands of retinoid receptors. , 2000, Current pharmaceutical design.
[28] T. Taniguchi,et al. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage , 1996, Nature.
[29] J. Darnell,et al. Stat3 as an Oncogene , 1999, Cell.
[30] T. Kavanagh. Gambling, chance and the discourse of power in ancien régime France , 1994 .
[31] Dillwyn Williams,et al. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid , 2005, British Journal of Cancer.
[32] S. Roy,et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. McCormick,et al. The RB and p53 pathways in cancer. , 2002, Cancer cell.
[34] D. Kalvakolanu,et al. Chromosomal localization of human GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[35] W. Gerald,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.
[36] D. Scudiero,et al. New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.
[37] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[38] H. Moch,et al. Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma , 2004, Journal of Clinical Pathology.
[39] P. Houghton,et al. Potentiation of neuroblastoma metastasis by loss of caspase-8 , 2006, Nature.
[40] Roland Lang,et al. SOCS3 regulates the plasticity of gp130 signaling , 2003, Nature Immunology.
[41] Francesco Pagano,et al. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours , 1998, Oncogene.
[42] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[43] al. et,et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia , 1993, Science.
[44] Lloyd J. Old,et al. The roles of IFNγ in protection against tumor development and cancer immunoediting , 2002 .
[45] D. Kalvakolanu,et al. Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo , 2005, Clinical Cancer Research.
[46] S. Korsmeyer,et al. Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death , 1995, Science.
[47] J. Choe,et al. Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[48] Lucia Altucci,et al. The promise of retinoids to fight against cancer , 2001, Nature Reviews Cancer.
[49] I. Tomlinson,et al. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase , 2003, Annals of medicine.
[50] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[51] W. Marston Linehan,et al. Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas , 1998, Nature Genetics.
[52] P Jay,et al. Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.
[53] J. Herman,et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.